Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Am J Gastroenterol

Retrieve available abstracts of 145 articles:
HTML format



Single Articles


    May 2020
  1. DULAI PS, Battat R, Barsky M, Nguyen NH, et al
    Incorporating Fecal Calprotectin Into Clinical Practice for Patients With Moderate-to-Severely Active Ulcerative Colitis Treated With Biologics or Small-Molecule Inhibitors.
    Am J Gastroenterol. 2020 May 7. doi: 10.14309/ajg.0000000000000596.
    PubMed     Abstract available


    April 2020
  2. MIRANDA E, Meza R, Kolbach M, Torres J, et al
    Sweet Syndrome in Pediatric Active Ulcerative Colitis.
    Am J Gastroenterol. 2020 Apr 27. doi: 10.14309/ajg.0000000000000645.
    PubMed    


  3. LIMDI JK
    Continuing Medical Education Questions: April 2020: Men with Inflammatory Bowel Disease: Sexual Function, Fertility, Medication Safety, and Prostate Cancer.
    Am J Gastroenterol. 2020;115:506.
    PubMed    


    February 2020
  4. KEDIA S, Mouli VP, Kamat N, Sankar J, et al
    Risk of Tuberculosis in Patients With Inflammatory Bowel Disease on Infliximab or Adalimumab Is Dependent on the Local Disease Burden of Tuberculosis: A Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2020 Feb 6. doi: 10.14309/ajg.0000000000000527.
    PubMed     Abstract available


  5. HAMMAMI MB, Mahadevan U
    Men With Inflammatory Bowel Disease: Sexual Function, Fertility, Medication Safety, and Prostate Cancer.
    Am J Gastroenterol. 2020 Feb 4. doi: 10.14309/ajg.0000000000000515.
    PubMed     Abstract available


    January 2020
  6. TARGOWNIK LE, Kaplan GG, Witt J, Bernstein CN, et al
    Longitudinal Trends in the Direct Costs and Health Care Utilization Ascribable to Inflammatory Bowel Disease in the Biologic Era: Results From a Canadian Population-Based Analysis.
    Am J Gastroenterol. 2020;115:128-137.
    PubMed     Abstract available


    December 2019
  7. CHATEAU T, Feakins R, Marchal-Bressenot A, Magro F, et al
    Histological Remission in Ulcerative Colitis: Under the Microscope Is the Cure.
    Am J Gastroenterol. 2019 Dec 5. doi: 10.14309/ajg.0000000000000437.
    PubMed     Abstract available


    November 2019
  8. CAZZAGON N, Lemoinne S, El Mouhadi S, Trivedi PJ, et al
    The Complementary Value of Magnetic Resonance Imaging and Vibration-Controlled Transient Elastography for Risk Stratification in Primary Sclerosing Cholangitis.
    Am J Gastroenterol. 2019 Nov 14. doi: 10.14309/ajg.0000000000000461.
    PubMed     Abstract available


  9. LEI DK, Ollech JE, Andersen M, Weisshof R, et al
    Long-Duration Oral Vancomycin to Treat Clostridioides difficile in Patients With Inflammatory Bowel Disease Is Associated With a Low Rate of Recurrence.
    Am J Gastroenterol. 2019 Nov 7. doi: 10.14309/ajg.0000000000000460.
    PubMed     Abstract available


  10. AGRAWAL S, Khanna U, Fernandez AP, Irfan M, et al
    Linear Immunoglobulin A Bullous Dermatosis Associated With Ulcerative Colitis.
    Am J Gastroenterol. 2019 Nov 6. doi: 10.14309/ajg.0000000000000449.
    PubMed    


  11. BOOTH AT, Forster E, Curran T, George V, et al
    Gastrocolic Fistula Involving the Pancreas in a Patient With Crohn's Disease.
    Am J Gastroenterol. 2019;114:1823-1824.
    PubMed    


    October 2019
  12. VISCIDO A, Latella G, Frieri G
    Topical Aminosalicylates and Histologic Healing in Ulcerative Colitis.
    Am J Gastroenterol. 2019 Oct 14. doi: 10.14309/ajg.0000000000000427.
    PubMed    


  13. YANG DH, Park SJ, Kim HS, Park YS, et al
    High-Definition Chromoendoscopy Versus High-Definition White Light Colonoscopy for Neoplasia Surveillance in Ulcerative Colitis: A Randomized Controlled Trial.
    Am J Gastroenterol. 2019;114:1642-1648.
    PubMed     Abstract available


    September 2019
  14. COHEN ER, Salem M, Ha C
    Managing Immunosuppressed Patients With Inflammatory Bowel Disease During a Measles Outbreak.
    Am J Gastroenterol. 2019 Sep 6. doi: 10.14309/ajg.0000000000000396.
    PubMed    


  15. WALLENHORST T, Jacques J, Bouguen G, Pagenault M, et al
    Successful Closure of a Rectal Fistula of Crohn's Disease Using Endoscopic Submucosal Dissection Combined With an Over-the-Scope Clip.
    Am J Gastroenterol. 2019;114:1416.
    PubMed    


    August 2019
  16. GREUTER T, Vavricka SR, Scharl M
    Response to Al Sulais et al.
    Am J Gastroenterol. 2019;114:1346-1347.
    PubMed    


  17. AL SULAIS E, AlAmeel T
    Family History Is a Risk Factor for Developing Malignancies.
    Am J Gastroenterol. 2019;114:1346.
    PubMed    


  18. SIMSEK M, de Boer NKH
    Mesalazine and Nephrolithiasis: Leave No Stone Unturned.
    Am J Gastroenterol. 2019;114:1359-1360.
    PubMed    


  19. LU C, Holubar SD, Rieder F
    How I Approach the Management of Stricturing Crohn's Disease.
    Am J Gastroenterol. 2019;114:1181-1184.
    PubMed    


    July 2019
  20. LIAO KF, Lai SW
    Association Between Inflammatory Bowel Disease and Hip Fracture.
    Am J Gastroenterol. 2019 Jul 31. doi: 10.14309/ajg.0000000000000344.
    PubMed    


  21. BAR-GIL SHITRIT A, Ben Ya'acov A, Livovsky DM, Cuker T, et al
    Exposure to Vedolizumab in IBD Pregnant Women Appears of Low Risk for Mother and Neonate: A First Prospective Comparison Study.
    Am J Gastroenterol. 2019;114:1172-1175.
    PubMed     Abstract available


  22. BRAUN T, Di Segni A, BenShoshan M, Neuman S, et al
    Individualized Dynamics in the Gut Microbiota Precede Crohn's Disease Flares.
    Am J Gastroenterol. 2019;114:1142-1151.
    PubMed     Abstract available


  23. BISHNOI A, Kaushik A, Banerjee N, Nada R, et al
    Asymptomatic Macrocheilia in an Adult Woman.
    Am J Gastroenterol. 2019;114:1022.
    PubMed    


    June 2019
  24. KNOX NC, Forbes JD, Peterson CL, Van Domselaar G, et al
    The Gut Microbiome in Inflammatory Bowel Disease: Lessons Learned From Other Immune-Mediated Inflammatory Diseases.
    Am J Gastroenterol. 2019 Jun 20. doi: 10.14309/ajg.0000000000000305.
    PubMed     Abstract available


  25. PITTET LF, Verolet CM, Michetti P, Girardin M, et al
    High Immunogenicity of the Pneumococcal Conjugated Vaccine in Immunocompromised Adults With Inflammatory Bowel Disease.
    Am J Gastroenterol. 2019 Jun 13. doi: 10.14309/ajg.0000000000000289.
    PubMed     Abstract available


    May 2019
  26. MANOSA M, Chaparro M, Juan A, Arajol C, et al
    Immunomodulatory Therapy Does Not Increase the Risk of Cancer in Persons With Inflammatory Bowel Disease and a History of Extracolonic Cancers.
    Am J Gastroenterol. 2019;114:771-776.
    PubMed     Abstract available


  27. LICHTENSTEIN GR, Loftus EV, Isaacs KL, Regueiro MD, et al
    Response to Chapman and Jones.
    Am J Gastroenterol. 2019;114:828.
    PubMed    


  28. LICHTENSTEIN GR, Loftus EV, Isaacs KL, Regueiro MD, et al
    Response to Ribaldone.
    Am J Gastroenterol. 2019;114:826-827.
    PubMed    


  29. CHAPMAN BJ, Jones GB
    Underscoring the Biochemical Overlap Between Crohn's Disease and Depression.
    Am J Gastroenterol. 2019;114:827-828.
    PubMed    


  30. RIBALDONE DG
    ACG Clinical Guideline on Crohn's Disease: A Point of View from Europe.
    Am J Gastroenterol. 2019;114:826.
    PubMed    


  31. WU J, Lubman DM, Kugathasan S, Denson LA, et al
    Serum Protein Biomarkers of Fibrosis Aid in Risk Stratification of Future Stricturing Complications in Pediatric Crohn's Disease.
    Am J Gastroenterol. 2019;114:777-785.
    PubMed     Abstract available


    April 2019
  32. SINGH S, Proudfoot J, Dulai PS, Jairath V, et al
    Correction: No Benefit of Concomitant 5-Aminosalicylates in Patients With Ulcerative Colitis Escalated to Biologic Therapy: Pooled Analysis of Individual Participant Data From Clinical Trials.
    Am J Gastroenterol. 2019 Apr 29. doi: 10.14309/ajg.0000000000000254.
    PubMed    


  33. LONG MD, Rubin DT
    Histologic Remission in Ulcerative Colitis: Are We There Yet?
    Am J Gastroenterol. 2019 Apr 22. doi: 10.14309/ajg.0000000000000235.
    PubMed     Abstract available


  34. MENON T, Afzali A
    Inflammatory Bowel Disease: A Practical Path to Transitioning From Pediatric to Adult Care.
    Am J Gastroenterol. 2019 Apr 12. doi: 10.14309/ajg.0000000000000222.
    PubMed     Abstract available


  35. JAIN A, Nguyen NH, Proudfoot JA, Martin CF, et al
    Impact of Obesity on Disease Activity and Patient-Reported Outcomes Measurement Information System (PROMIS) in Inflammatory Bowel Diseases.
    Am J Gastroenterol. 2019;114:630-639.
    PubMed     Abstract available


    March 2019
  36. UNGARO R, Colombel JF, Lissoos T, Peyrin-Biroulet L, et al
    A Treat-to-Target Update in Ulcerative Colitis: A Systematic Review.
    Am J Gastroenterol. 2019 Mar 22. doi: 10.14309/ajg.0000000000000183.
    PubMed     Abstract available


  37. BARNES EL, Kappelman MD, Long MD, Evon DM, et al
    A Novel Patient-Reported Outcome-Based Evaluation (PROBE) of Quality of Life in Patients With Inflammatory Bowel Disease.
    Am J Gastroenterol. 2019 Mar 1. doi: 10.14309/ajg.0000000000000177.
    PubMed     Abstract available


  38. RUBIN DT, Ananthakrishnan AN, Siegel CA, Sauer BG, et al
    ACG Clinical Guideline: Ulcerative Colitis in Adults.
    Am J Gastroenterol. 2019;114:384-413.
    PubMed     Abstract available


  39. SINGH S, Jairath V
    Response to Gupta and Hanauer.
    Am J Gastroenterol. 2019;114:535-536.
    PubMed    


  40. HE Y, Zhu Z, Chen Y, Chen F, et al
    Development and Validation of a Novel Diagnostic Nomogram to Differentiate Between Intestinal Tuberculosis and Crohn's Disease: A 6-year Prospective Multicenter Study.
    Am J Gastroenterol. 2019;114:490-499.
    PubMed     Abstract available


  41. GUPTA N, Hanauer SB
    Too Soon to Discard 5-ASAs?
    Am J Gastroenterol. 2019;114:534-535.
    PubMed    


    February 2019
  42. HATA K, Anzai H, Ikeuchi H, Futami K, et al
    Surveillance Colonoscopy for Ulcerative Colitis-Associated Colorectal Cancer Offers Better Overall Survival in Real-World Surgically Resected Cases.
    Am J Gastroenterol. 2019 Feb 8. doi: 10.14309/ajg.0000000000000117.
    PubMed     Abstract available


  43. LUDVIGSSON JF, Mahl M, Sachs MC, Bjork J, et al
    Fracture Risk in Patients With Inflammatory Bowel Disease: A Nationwide Population-Based Cohort Study From 1964 to 2014.
    Am J Gastroenterol. 2019;114:291-304.
    PubMed     Abstract available


  44. FRIEDMAN S, Norgard BM
    Response to Zhao et al.
    Am J Gastroenterol. 2019;114:358-359.
    PubMed    


  45. BERENBLUM C
    An Issue of Control: Patient Perspectives on Use of Nutritional Interventions for IBD.
    Am J Gastroenterol. 2019;114:192-193.
    PubMed    


    January 2019
  46. SIEGEL CA
    Placing Value on Telemedicine for Inflammatory Bowel Disease.
    Am J Gastroenterol. 2019 Jan 30. doi: 10.14309/ajg.0000000000000151.
    PubMed     Abstract available


  47. BATTAT R, Duijvestein M, Guizzetti L, Choudhary D, et al
    Histologic Healing Rates of Medical Therapies for Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Am J Gastroenterol. 2019 Jan 25. doi: 10.14309/ajg.0000000000000111.
    PubMed     Abstract available


  48. ZHAO S, Wang J, Zhao Z
    Inflammatory Bowel Disease and Risk of Erectile Dysfunction: What Does the Current Evidence Tell Us?
    Am J Gastroenterol. 2019 Jan 18. doi: 10.14309/ajg.0000000000000070.
    PubMed    


  49. LICHTENSTEIN GR, Loftus EV Jr, Isaacs KL, Regueiro MD, et al
    Response to Chamberlin and Borody.
    Am J Gastroenterol. 2019;114:171-174.
    PubMed    


  50. CHAMBERLIN W, Borody T
    Comment on 2018 ACG Clinical Guideline: Antibiotics in Crohn's Disease.
    Am J Gastroenterol. 2019;114:170-171.
    PubMed    


  51. SAEZ-GONZALEZ E, Salavert M, Cerrillo E, Moret I, et al
    Secondary Haemophagocytic Syndrome and Overlapping Immune Reconstitution Syndrome: Life-Threatening Complications of Anti-TNF-alpha Treatment for Crohn's Disease.
    Am J Gastroenterol. 2019;114:177-179.
    PubMed    


  52. LIU PH, Lebwohl B, Burke KE, Ivey KL, et al
    Dietary Gluten Intake and Risk of Microscopic Colitis Among US Women without Celiac Disease: A Prospective Cohort Study.
    Am J Gastroenterol. 2019;114:127-134.
    PubMed     Abstract available


    November 2018
  53. SHEN B, Kochhar G, Hull TL
    Bridging Medical and Surgical Treatment of Inflammatory Bowel Disease: The Role of Interventional IBD.
    Am J Gastroenterol. 2018 Nov 21. pii: 10.1038/s41395-018-0416.
    PubMed    


  54. VERNERO M, Astegiano M, Ribaldone DG
    New Onset of Inflammatory Bowel Disease in Three Patients Undergoing IL-17A Inhibitor Secukinumab: A Case Series.
    Am J Gastroenterol. 2018 Nov 14. pii: 10.1038/s41395-018-0422.
    PubMed    


  55. COHEN-MEKELBURG S, Rosenblatt R, Gold S, Shen N, et al
    Fragmented Care is Prevalent among Inflammatory Bowel Disease Readmissions and is Associated with Worse Outcomes.
    Am J Gastroenterol. 2018 Nov 12. pii: 10.1038/s41395-018-0417.
    PubMed     Abstract available


  56. CROSS RK, Langenberg P, Regueiro M, Schwartz DA, et al
    A Randomized Controlled Trial of TELEmedicine for Patients with Inflammatory Bowel Disease (TELE-IBD).
    Am J Gastroenterol. 2018 Nov 8. pii: 10.1038/s41395-018-0272.
    PubMed     Abstract available


  57. NARULA N, Peerani F, Meserve J, Kochhar G, et al
    Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.
    Am J Gastroenterol. 2018 Nov 2. pii: 10.1038/s41395-018-0401.
    PubMed     Abstract available


    October 2018

  58. Inflammatory Bowel Disease (Abstracts 568-744).
    Am J Gastroenterol. 2018 Oct 25. pii: 10.1038/s41395-018-0296.
    PubMed    


  59. CHAPARRO M, Gisbert JP
    Pregnancy and Inflammatory Bowel Disease: A Long Way to Go.
    Am J Gastroenterol. 2018 Oct 24. pii: 10.1038/s41395-018-0379.
    PubMed    


  60. BYE WA, Ma C, Nguyen TM, Parker CE, et al
    Strategies for Detecting Colorectal Cancer in Patients with Inflammatory Bowel Disease: A Cochrane Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2018 Oct 23. pii: 10.1038/s41395-018-0354.
    PubMed     Abstract available


  61. MA D, Wong W, Aviado J, Rodriguez C, et al
    Safety and Tolerability of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease.
    Am J Gastroenterol. 2018 Oct 17. pii: 10.1038/s41395-018-0368.
    PubMed     Abstract available


  62. SCHARL S, Barthel C, Rossel JB, Biedermann L, et al
    Malignancies in Inflammatory Bowel Disease: Frequency, Incidence and Risk Factors-Results from the Swiss IBD Cohort Study.
    Am J Gastroenterol. 2018 Oct 17. pii: 10.1038/s41395-018-0360.
    PubMed     Abstract available



  63. Clinical Vignettes/Case Reports - Inflammatory Bowel Disease.
    Am J Gastroenterol. 2018 Oct 12. pii: 10.1038/s41395-018-0312.
    PubMed    



  64. Clinical Vignettes/Case Reports - Inflammatory Bowel Disease.
    Am J Gastroenterol. 2018 Oct 8. pii: 10.1038/s41395-018-0342.
    PubMed    



  65. Inflammatory Bowel Disease.
    Am J Gastroenterol. 2018 Oct 8. pii: 10.1038/s41395-018-0327.
    PubMed    


    September 2018
  66. ALMARIO CV, Chen MS, Spiegel BMR
    Reply to Johnson et al. Regarding Optimizing Selection of Biologics in Inflammatory Bowel Disease: Development of an Online Patient Decision Aid Using Conjoint Analysis.
    Am J Gastroenterol. 2018 Sep 13. pii: 10.1038/s41395-018-0279.
    PubMed    


  67. NG SC, Kaplan GG, Tang W, Banerjee R, et al
    Population Density and Risk of Inflammatory Bowel Disease: A Prospective Population-Based Study in 13 Countries or Regions in Asia-Pacific.
    Am J Gastroenterol. 2018 Sep 3. pii: 10.1038/s41395-018-0233.
    PubMed     Abstract available


    August 2018
  68. JAIRATH V
    Hyperbaric Oxygen for Hospitalized patients with Ulcerative Colitis.
    Am J Gastroenterol. 2018 Aug 29. pii: 10.1038/s41395-018-0224.
    PubMed     Abstract available


  69. AXELRAD JE, Joelson A, Green PHR, Lawlor G, et al
    Enteric Infections Are Common in Patients with Flares of Inflammatory Bowel Disease.
    Am J Gastroenterol. 2018 Aug 3. pii: 10.1038/s41395-018-0211.
    PubMed     Abstract available


    July 2018
  70. FELD LD, Rubin DT, Feld AD
    Legal Risks and Considerations Associated with Inflammatory Bowel Disease: A Primer.
    Am J Gastroenterol. 2018 Jul 16. pii: 10.1038/s41395-018-0204.
    PubMed    


  71. FRIEDMAN S, Magnussen B, O'Toole A, Fedder J, et al
    Increased Use of Medications for Erectile Dysfunction in Men With Ulcerative Colitis and Crohn's Disease Compared to Men Without Inflammatory Bowel Disease: A Nationwide Cohort Study.
    Am J Gastroenterol. 2018 Jul 10. pii: 10.1038/s41395-018-0177.
    PubMed     Abstract available


  72. JOHNSON FR, Reed S, Gonzalez JM
    Letter to the Editor Regarding Optimizing Selection of Biologics in Inflammatory Bowel Disease: Development of an Online Patient Decision Aid Using Conjoint Analysis.
    Am J Gastroenterol. 2018 Jul 3. pii: 10.1038/s41395-018-0186.
    PubMed    


    June 2018
  73. NARULA N, Peerani F, Meserve J, Kochhar G, et al
    Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.
    Am J Gastroenterol. 2018 Jun 27. pii: 10.1038/s41395-018-0162.
    PubMed     Abstract available


  74. SINGH S, Proudfoot JA, Dulai PS, Jairath V, et al
    No Benefit of Concomitant 5-Aminosalicylates in Patients With Ulcerative Colitis Escalated to Biologic Therapy: Pooled Analysis of Individual Participant Data From Clinical Trials.
    Am J Gastroenterol. 2018 Jun 21. pii: 10.1038/s41395-018-0144.
    PubMed     Abstract available


  75. NHU QM, Chiao H, Moawad FJ, Bao F, et al
    The Anti-alpha4beta7 Integrin Therapeutic Antibody for Inflammatory Bowel Disease, Vedolizumab, Ameliorates Eosinophilic Esophagitis: a Novel Clinical Observation.
    Am J Gastroenterol. 2018 Jun 12. pii: 10.1038/s41395-018-0145.
    PubMed    


  76. LEVENSTEIN S, Prantera C
    Depression and Disease Course in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2018 Jun 11. pii: 10.1038/s41395-018-0111.
    PubMed    


  77. MAO R, Chen MH
    Networked Clinical Study Collaboration on Inflammatory Bowel Disease in China.
    Am J Gastroenterol. 2018 Jun 7. pii: 10.1038/s41395-018-0148.
    PubMed    


  78. MOHAPATRA S, Singh DP, Alcid D, Pitchumoni CS, et al
    Beyond O&P Times Three.
    Am J Gastroenterol. 2018 Jun 5. pii: 10.1038/s41395-018-0083.
    PubMed     Abstract available


    May 2018
  79. ORDAS I, Domenech E, Manosa M, Garcia-Sanchez V, et al
    Post-operative morbidity and mortality of a cohort of steroid refractory acute severe ulcerative colitis: Nationwide multicenter study of the GETECCU ENEIDA Registry.
    Am J Gastroenterol. 2018 May 1. pii: 10.1038/s41395-018-0057.
    PubMed     Abstract available


  80. SCHILLER LR
    Evaluation of chronic diarrhea and irritable bowel syndrome with diarrhea in adults in the era of precision medicine.
    Am J Gastroenterol. 2018 May 1. pii: 10.1038/s41395-018-0032.
    PubMed     Abstract available


    April 2018
  81. MATSUSHITA M, Fukata N, Omiya M, Nishio A, et al
    Pathophysiology of the Appendix in Ulcerative Colitis.
    Am J Gastroenterol. 2018;113:622.
    PubMed    


    March 2018
  82. JENSEN CB, Angquist LH, Mendall MA, Sorensen TIA, et al
    Childhood body mass index and risk of inflammatory bowel disease in adulthood: a population-based cohort study.
    Am J Gastroenterol. 2018 Mar 13. pii: 10.1038/s41395-018-0031.
    PubMed     Abstract available


  83. DEEKE SA, Starr AE, Ning Z, Ahmadi S, et al
    Mucosal-luminal interface proteomics reveals biomarkers of pediatric inflammatory bowel disease-associated colitis.
    Am J Gastroenterol. 2018 Mar 12. pii: 10.1038/s41395-018-0024.
    PubMed     Abstract available


  84. VEERAPPAN GR
    Continuing Medical Education Questions: March 2018: Long-Term Safety of In Utero Exposure to Anti-TNFalpha Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study.
    Am J Gastroenterol. 2018;113:404.
    PubMed    


    February 2018
  85. DAI C, Jiang M, Cao Q
    Association between Depression and More Aggressive Inflammatory Bowel Disease.
    Am J Gastroenterol. 2018 Feb 27. pii: 10.1038/s41395-018-0016.
    PubMed    


  86. CHAPARRO M, Verreth A, Lobaton T, Gravito-Soares E, et al
    Long-Term Safety of In Utero Exposure to Anti-TNFalpha Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study.
    Am J Gastroenterol. 2018 Feb 20. pii: ajg2017501. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


  87. GRACIE DJ, Hamlin PJ, Ford AC
    Longitudinal impact of IBS-type symptoms on disease activity, healthcare utilization, psychological health, and quality of life in inflammatory bowel disease.
    Am J Gastroenterol. 2018 Feb 16. pii: 10.1038/s41395-018-0021.
    PubMed     Abstract available


  88. DULAI PS, Buckey JC Jr., Raffals LE, Swoger JM, et al
    Hyperbaric oxygen therapy is well tolerated and effective for ulcerative colitis patients hospitalized for moderate-severe flares: a phase 2A pilot multi-center, randomized, double-blind, sham-controlled trial.
    Am J Gastroenterol. 2018 Feb 16. pii: 10.1038/s41395-018-0005.
    PubMed     Abstract available


  89. BARNES EL, Kappelman MD
    Editorial: Increasing Incidence of Pediatric Inflammatory Bowel Disease in France: Implications for Etiology, Diagnosis, Prognosis, and Treatment.
    Am J Gastroenterol. 2018;113:273-275.
    PubMed     Abstract available


  90. TOMINAGA K, Tsuchiya A, Honda Y, Abe T, et al
    A Case of Panenteritis With Massive IgG4-Positive Plasma Cell Infiltration Developed 26 Years After Total Proctocolectomy for Ulcerative Colitis.
    Am J Gastroenterol. 2018;113:173.
    PubMed    


    January 2018
  91. LEWIS JD, Scott FI, Brensinger CM, Roy JA, et al
    Increased Mortality Rates With Prolonged Corticosteroid Therapy When Compared With Antitumor Necrosis Factor-alpha-Directed Therapy for Inflammatory Bowel Disease.
    Am J Gastroenterol. 2018 Jan 16. pii: ajg2017479. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


  92. JEURING SFG, Biemans VBC, van den Heuvel TRA, Zeegers MP, et al
    Corticosteroid Sparing in Inflammatory Bowel Disease is More Often Achieved in the Immunomodulator and Biological Era-Results from the Dutch Population-Based IBDSL Cohort.
    Am J Gastroenterol. 2018 Jan 9. pii: ajg2017482. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


    December 2017
  93. TAKENAKA K, Ohtsuka K, Kitazume Y, Matsuoka K, et al
    Utility of Magnetic Resonance Enterography For Small Bowel Endoscopic Healing in Patients With Crohn's Disease.
    Am J Gastroenterol. 2017 Dec 19. pii: ajg2017464. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


  94. ALMARIO CV, Keller MS, Chen M, Lasch K, et al
    Optimizing Selection of Biologics in Inflammatory Bowel Disease: Development of an Online Patient Decision Aid Using Conjoint Analysis.
    Am J Gastroenterol. 2017 Dec 5. pii: ajg2017470. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


  95. MA C, Moran GW, Benchimol EI, Targownik LE, et al
    Surgical Rates for Crohn's Disease are Decreasing: A Population-Based Time Trend Analysis and Validation Study.
    Am J Gastroenterol. 2017;112:1840-1848.
    PubMed     Abstract available


    November 2017
  96. KOCHAR B, Barnes EL, Long MD, Cushing KC, et al
    Depression Is Associated With More Aggressive Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017 Nov 14. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


  97. CLICK B, Anderson AM, Koutroubakis IE, Rivers CR, et al
    Peripheral Eosinophilia in Patients With Inflammatory Bowel Disease Defines an Aggressive Disease Phenotype.
    Am J Gastroenterol. 2017 Nov 7. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


  98. BERNSTEIN CN, Kornbluth A
    Yes, We Are Still Talking about Cylosporin vs. Infliximab in Steroid Resistant Acute Severe Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:1719-1721.
    PubMed     Abstract available


  99. ABE K, Nakamura N, Isono A, Toyota H, et al
    Inflammatory Bowel Disease in an Elderly Woman After Nivolumab Administration.
    Am J Gastroenterol. 2017;112:1636.
    PubMed    


    October 2017
  100. MARTIN L, Peche W, Peterson K, Wan Y, et al
    Population Based Paternity Rate and Partner Birth Outcomes Among Utah Men With Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017 Oct 3. doi: 10.1038/ajg.2017.
    PubMed     Abstract available



  101. Clinical Vignettes/Case Reports - Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112.
    PubMed    



  102. Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112.
    PubMed    



  103. Submitted, Not Presented: Clinical Vignettes/Case Reports - Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112.
    PubMed    



  104. Submitted, Not Presented: Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112.
    PubMed    


  105. FISCHER S, Rath T, Geppert CI, Manger B, et al
    Long-term Combination Therapy with Anti-TNF plus Vedolizumab Induces and Maintains Remission in Therapy-refractory Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:1621-1623.
    PubMed    


  106. ZHAO H, Xu W, Wang Z
    Sweet's Syndrome: An Unusual Extraintestinal Manifestation of Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112:1493.
    PubMed    


  107. BUCHNER AM, Lichtenstein GR
    Editorial: Endoscopic Scoring Systems in Crohn's Disease for Evaluation of Responsiveness to Treatment: Are we Ready for the Prime Time of Endoscopic Assessment?
    Am J Gastroenterol. 2017;112:1593-1595.
    PubMed     Abstract available


  108. KHANNA R, Zou G, Stitt L, Feagan BG, et al
    Responsiveness of Endoscopic Indices of Disease Activity for Crohn's Disease.
    Am J Gastroenterol. 2017;112:1584-1592.
    PubMed     Abstract available


    September 2017
  109. ESTEVEZ-BOULLOSA P, Fernandez-Fernandez N, Pineda-Marino JR, Martinez-Cadilla J, et al
    Sweet's Syndrome: An Unusual Extraintestinal Manifestation of Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112:1363.
    PubMed    


  110. BENCHIMOL EI, Kaplan GG, Otley AR, Nguyen GC, et al
    Corrigendum: Rural and Urban Residence During Early Life Is Associated with a Lower Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort Study.
    Am J Gastroenterol. 2017;112:1485.
    PubMed     Abstract available


    August 2017
  111. GHIONE S, Sarter H, Fumery M, Armengol-Debeir L, et al
    Dramatic Increase in Incidence of Ulcerative Colitis and Crohn's Disease (1988-2011): A Population-Based Study of French Adolescents.
    Am J Gastroenterol. 2017 Aug 15. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


    July 2017
  112. BENCHIMOL EI, Kaplan GG, Otley AR, Nguyen GC, et al
    Rural and Urban Residence During Early Life is Associated with a Lower Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort Study.
    Am J Gastroenterol. 2017 Jul 25. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


  113. YAMADA A, Komaki Y, Patel N, Komaki F, et al
    Risk of Postoperative Complications Among Inflammatory Bowel Disease Patients Treated Preoperatively With Vedolizumab.
    Am J Gastroenterol. 2017 Jul 18. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


  114. ORDAS I, Domenech E, Manosa M, Garcia-Sanchez V, et al
    Long-Term Efficacy and Safety of Cyclosporine in a Cohort of Steroid-Refractory Acute Severe Ulcerative Colitis Patients from the ENEIDA Registry (1989-2013): A Nationwide Multicenter Study.
    Am J Gastroenterol. 2017 Jul 4. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


  115. DAI C, Jiang M, Sun MJ
    The Risk of Gallstone Disease Following Colectomy for Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:1165.
    PubMed    


  116. MATSUSHITA M, Fukata N, Omiya M, Okazaki K, et al
    Nationwide Studies of Hematological Malignancies in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017;112:1171-1172.
    PubMed    


    June 2017
  117. MYRELID P, Landerholm K, Nordenvall C, Pinkney TD, et al
    Appendectomy and the Risk of Colectomy in Ulcerative Colitis: A National Cohort Study.
    Am J Gastroenterol. 2017 Jun 27. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


  118. PATIL DT, Odze RD
    Backwash Is Hogwash: The Clinical Significance of Ileitis in Ulcerative Colitis.
    Am J Gastroenterol. 2017 Jun 20. doi: 10.1038/ajg.2017.
    PubMed    


  119. KOMEDA Y, Kashida H, Sakurai T, Kono M, et al
    A Case of Type II Enteropathy-Associated T-Cell Lymphoma in a Patient With Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:833.
    PubMed    


    May 2017
  120. FARRAYE FA, Melmed GY, Lichtenstein GR, Kane SV, et al
    Corrigendum: ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017 May 23. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


  121. CHAPARRO M, Ramas M, Benitez JM, Lopez-Garcia A, et al
    Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida Registry.
    Am J Gastroenterol. 2017 May 23. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


    April 2017
  122. BENCHIMOL EI, Bernstein CN, Bitton A, Carroll MW, et al
    Trends in Epidemiology of Pediatric Inflammatory Bowel Disease in Canada: Distributed Network Analysis of Multiple Population-Based Provincial Health Administrative Databases.
    Am J Gastroenterol. 2017 Apr 18. doi: 10.1038/ajg.2017.
    PubMed     Abstract available


    March 2017
  123. TAN NY, Majumder S, Sridharan M, Kerr SE, et al
    Metastatic Epstein-Barr Virus-Positive Lymphoepithelioma-Like Cholangiocarcinoma in a Young Man With Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:518-520.
    PubMed    


  124. LIMSRIVILAI J, Shreiner AB, Pongpaibul A, Laohapand C, et al
    Meta-Analytic Bayesian Model For Differentiating Intestinal Tuberculosis from Crohn's Disease.
    Am J Gastroenterol. 2017;112:415-427.
    PubMed     Abstract available


    February 2017
  125. FUMERY M, Seksik P, Auzolle C, Munoz-Bongrand N, et al
    Postoperative Complications after Ileocecal Resection in Crohn's Disease: A Prospective Study From the REMIND Group.
    Am J Gastroenterol. 2017;112:337-345.
    PubMed     Abstract available


  126. JEURING SF, van den Heuvel TR, Liu LY, Zeegers MP, et al
    Improvements in the Long-Term Outcome of Crohn's Disease Over the Past Two Decades and the Relation to Changes in Medical Management: Results from the Population-Based IBDSL Cohort.
    Am J Gastroenterol. 2017;112:325-336.
    PubMed     Abstract available


    January 2017
  127. MARK-CHRISTENSEN A, Brandsborg S, Laurberg S, Johansen N, et al
    Increased Risk of Gallstone Disease Following Colectomy for Ulcerative Colitis.
    Am J Gastroenterol. 2017 Jan 24. doi: 10.1038/ajg.2016.
    PubMed     Abstract available


  128. OSTERMAN M, Gastonguay MR, Lasch K, Barocas MA, et al
    Corrigendum: 2016 ACG Abstracts-Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017 Jan 10. doi: 10.1038/ajg.2016.
    PubMed    


  129. FARRAYE FA, Melmed GY, Lichtenstein GR, Kane SV, et al
    ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2017 Jan 10. doi: 10.1038/ajg.2016.
    PubMed     Abstract available


  130. ANZAI H, Hata K, Ishihara S, Osada T, et al
    Caution Against the Resect-and-Discard Strategy for Dysplastic Polyps in Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:189-191.
    PubMed    


  131. MATSUSHITA M, Nishio A, Seki T, Okazaki K, et al
    Pathogenesis and Carcinogenesis of the Appendix in Ulcerative Colitis.
    Am J Gastroenterol. 2017;112:184.
    PubMed    


  132. CUI DJ, Zhao X, Hu M
    Impact of Crohn's Disease Duration on the Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis.
    Am J Gastroenterol. 2017;112:185.
    PubMed    


    December 2016
  133. CASANOVA MJ, Chaparro M, Garcia-Sanchez V, Nantes O, et al
    Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.
    Am J Gastroenterol. 2016 Dec 13. doi: 10.1038/ajg.2016.
    PubMed     Abstract available


  134. DAI C, Jiang M, Sun MJ
    Statins and the Risk of Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111:1851.
    PubMed    


    November 2016
  135. ZIDAR N, Tepes K
    Cytomegalovirus Reactivation in Ulcerative Colitis: What Can We Learn From Pathology?
    Am J Gastroenterol. 2016;111:1658.
    PubMed    


    October 2016
  136. KHALILI H, Neovius M, Ekbom A, Ludvigsson JF, et al
    Oral Contraceptive Use and Risk of Ulcerative Colitis Progression: A Nationwide Study.
    Am J Gastroenterol. 2016 Oct 11. doi: 10.1038/ajg.2016.
    PubMed     Abstract available


  137. PARK S, Abdi T, Gentry M, Laine L, et al
    Histological Disease Activity as a Predictor of Clinical Relapse Among Patients With Ulcerative Colitis: Systematic Review and Meta-Analysis.
    Am J Gastroenterol. 2016 Oct 11. doi: 10.1038/ajg.2016.
    PubMed     Abstract available



  138. Clinical Vignettes/Case Reports - Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111.
    PubMed    



  139. Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111.
    PubMed    



  140. Submitted, Not Presented: Clinical Vignettes/Case Reports - Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111.
    PubMed    



  141. Submitted, Not Presented: Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111.
    PubMed    


  142. LEVENSTEIN S, Prantera C
    Psychological Factors, Symptoms, and Mucosal Inflammation in Inflammatory Bowel Disease.
    Am J Gastroenterol. 2016;111:1498-1499.
    PubMed    


  143. KHALILI H
    Editorial: Statins for Inflammatory Bowel Disease: Expanding the Scope of Prevention.
    Am J Gastroenterol. 2016;111:1424-1426.
    PubMed     Abstract available


    June 2016
  144. MARASCO G, Scaioli E, Renzulli M, Colecchia A, et al
    MRI Patterns in a Case of 6-Thioguanine-Related Hepatic Sinusoidal Obstruction Syndrome.
    Am J Gastroenterol. 2016;111:767.
    PubMed    


    May 2016
  145. DEEPAK P, Fletcher JG, Fidler JL, Barlow JM, et al
    Radiological Response Is Associated With Better Long-Term Outcomes and Is a Potential Treatment Target in Patients With Small Bowel Crohn's Disease.
    Am J Gastroenterol. 2016 May 10. doi: 10.1038/ajg.2016.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: